PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
30-Sep-2024 Cardiovascular Diagnostics Market Poised for Significant Growth Amidst Increasing Prevalence of Heart Diseases Pristine Market Insights
30-Sep-2024 Medacta Hosts Inaugural Capital Markets Day, Showcasing Responsible Innovation and Effective Growth Strategy Medacta Group SA
30-Sep-2024 CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review CluePoints
30-Sep-2024 Antimicrobial Dressing Market Thrives on Rising Demand for Effective Post-Surgical Care Pristine Market Insights
30-Sep-2024 Modern Dental Group Shared the Technological Innovation in Dentistry Along the Development of New Quality Productive Forces in CCB International Forum Modern Dental Group Limited
30-Sep-2024 Genflow Biosciences PLC Announces Half-year Report AccessWire
30-Sep-2024 Formycon and Fresenius Kabi receive FDA approval for FYB202/ OtulfiTM (ustekinumab-aauz) Formycon AG
30-Sep-2024 T2D.com Announces That Former NFL Linebacker Alec Ogletree Has Joined the Company as a Co-Founder AccessWire
29-Sep-2024 Brief discussion on the development and course of plant extract in China Xuancheng Quality Herb Co.,ltd
28-Sep-2024 Quantum Biopharma Provides Corporate Update Newswire
28-Sep-2024 Quantum Biopharma Provides Corporate Update AccessWire
27-Sep-2024 DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update Nyxoah SA.
27-Sep-2024 Ensysce Biosciences Receives Notice from Nasdaq AccessWire
27-Sep-2024 FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz) Formycon AG
27-Sep-2024 POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP™ Newswire
27-Sep-2024 POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM) AccessWire
27-Sep-2024 Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Sanofi
27-Sep-2024 During European Myeloma Day, MPE highlights the importance of improving access to clinical trials Myeloma Patients Europe
27-Sep-2024 CQDM and Epitopea Fund the Development and Validation of CryptoMapTM, a Platform Enabling the Development of RNA-based Immunotherapies Epitopea
27-Sep-2024 LEO Pharma Presents Late-Breaking Results from the Phase 2a Mechanism of Action Trial of Temtokibart and Dupilumab in Moderate-to-Severe Atopic Dermatitis at the 2024 EADV Annual Meeting LEO Pharma A/S